CN105169474B - Polypeptide material capable of carrying out self-assembly to form hydrogel under neutral pH condition and applications thereof - Google Patents
Polypeptide material capable of carrying out self-assembly to form hydrogel under neutral pH condition and applications thereof Download PDFInfo
- Publication number
- CN105169474B CN105169474B CN201510521915.1A CN201510521915A CN105169474B CN 105169474 B CN105169474 B CN 105169474B CN 201510521915 A CN201510521915 A CN 201510521915A CN 105169474 B CN105169474 B CN 105169474B
- Authority
- CN
- China
- Prior art keywords
- hydrogel
- polypeptide material
- neutral
- alanine
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000017 hydrogel Substances 0.000 title claims abstract description 56
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 49
- 239000000463 material Substances 0.000 title claims abstract description 39
- 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 32
- 230000007935 neutral effect Effects 0.000 title claims abstract description 28
- 229920001184 polypeptide Polymers 0.000 title claims abstract description 24
- 238000001338 self-assembly Methods 0.000 title abstract description 6
- 150000001413 amino acids Chemical class 0.000 claims abstract description 9
- 238000004113 cell culture Methods 0.000 claims abstract description 9
- 238000002156 mixing Methods 0.000 claims abstract description 7
- 108010067520 RADA16-I Proteins 0.000 claims abstract description 5
- 230000002378 acidificating effect Effects 0.000 claims abstract description 5
- 230000006378 damage Effects 0.000 claims description 7
- 239000007864 aqueous solution Substances 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 239000004472 Lysine Substances 0.000 claims description 5
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 5
- 239000004475 Arginine Substances 0.000 claims description 4
- 239000006285 cell suspension Substances 0.000 claims description 4
- 230000008439 repair process Effects 0.000 claims description 4
- 210000004204 blood vessel Anatomy 0.000 claims description 3
- 210000000845 cartilage Anatomy 0.000 claims description 3
- 210000005036 nerve Anatomy 0.000 claims description 3
- 230000008929 regeneration Effects 0.000 claims description 3
- 238000011069 regeneration method Methods 0.000 claims description 3
- 239000004474 valine Substances 0.000 claims description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 2
- 239000001963 growth medium Substances 0.000 claims description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims 4
- 229910021529 ammonia Inorganic materials 0.000 claims 2
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 claims 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims 1
- 208000027418 Wounds and injury Diseases 0.000 claims 1
- 239000012467 final product Substances 0.000 claims 1
- 208000014674 injury Diseases 0.000 claims 1
- 239000002121 nanofiber Substances 0.000 abstract description 17
- 238000011065 in-situ storage Methods 0.000 abstract description 6
- 238000001727 in vivo Methods 0.000 abstract description 5
- 238000002347 injection Methods 0.000 abstract description 4
- 239000007924 injection Substances 0.000 abstract description 4
- 239000003937 drug carrier Substances 0.000 abstract description 3
- 230000004962 physiological condition Effects 0.000 abstract description 3
- 238000011068 loading method Methods 0.000 abstract description 2
- 210000004027 cell Anatomy 0.000 description 19
- 239000000499 gel Substances 0.000 description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 210000001519 tissue Anatomy 0.000 description 10
- 239000000243 solution Substances 0.000 description 8
- 210000001178 neural stem cell Anatomy 0.000 description 7
- 210000003050 axon Anatomy 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 5
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 5
- 230000010261 cell growth Effects 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 210000002744 extracellular matrix Anatomy 0.000 description 5
- 235000001014 amino acid Nutrition 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 230000004083 survival effect Effects 0.000 description 4
- 229910021642 ultra pure water Inorganic materials 0.000 description 4
- 239000012498 ultrapure water Substances 0.000 description 4
- 239000006143 cell culture medium Substances 0.000 description 3
- 239000003102 growth factor Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000003278 mimic effect Effects 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 108060003393 Granulin Proteins 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 238000012356 Product development Methods 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 230000028600 axonogenesis Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 238000012832 cell culture technique Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000007734 materials engineering Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000014511 neuron projection development Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
技术领域technical field
本发明属于材料制备领域,更具体地,涉及一种中性pH下自组装成水凝胶的多肽材料及其应用。The invention belongs to the field of material preparation, and more specifically relates to a polypeptide material self-assembled into a hydrogel at a neutral pH and an application thereof.
背景技术Background technique
三维多孔纳米支架能够模仿天然细胞外基质结构,为细胞生长提供支持,广泛应用于生物医学、组织工程学等研究领域。几乎所有的组织细胞在体内都是在三维条件下生长,细胞被包裹在由胶原纤维作为主要成分组成的纳米纤维水凝胶之中,此外,细胞外基质中还含有大量的不溶性基质蛋白和可溶性生长因子。但目前研究中细胞培养技术中所采用的大多都是二维培养,即细胞在培养板或者培养皿上进行培养,这与体内生长环境相差较大,影响细胞生长,甚至会引起细胞基因或者功能变化。如何体外构建具有模仿天然细胞外基质结构和功能的人工支架材料,为细胞提供三维生长环境一直是生物、医学以及材料工程领域基础研究和产品开发的热点。Three-dimensional porous nanoscaffolds can mimic the structure of natural extracellular matrix to provide support for cell growth, and are widely used in biomedicine, tissue engineering and other research fields. Almost all tissue cells grow in three-dimensional conditions in vivo, and the cells are wrapped in nanofibrous hydrogels composed of collagen fibers as the main component. In addition, the extracellular matrix also contains a large amount of insoluble matrix proteins and soluble growth factor. However, most of the cell culture techniques used in the current research are two-dimensional culture, that is, cells are cultured on culture plates or dishes, which is quite different from the growth environment in vivo, which affects cell growth and even affects cell genes or functions. Variety. How to construct artificial scaffold materials in vitro that mimic the structure and function of natural extracellular matrix and provide cells with a three-dimensional growth environment has always been a hot spot in basic research and product development in the fields of biology, medicine and materials engineering.
自组装短肽RADA16-I是4个重复的精氨酸-丙氨酸-天冬氨酸-丙氨酸序列,即(精氨酸-丙氨酸-天冬氨酸-丙氨酸)4,当其水溶液调节至pH=7时会形成由纳米纤维网络构成的水凝胶,与天然细胞外基质结构很相似,作为组织工程支架、药物载体和止血材料在生物医学工程领域有广泛的应用,是自组装短肽水凝胶材料的典型代表。但是一个显著的缺点是该材料水溶液具有明显的酸性(pH=3~4),不能与细胞悬液和活性分子直接混合原位成凝胶,即很难实现细胞包埋在RADA 16-I水凝胶中进行三维生长。The self-assembled short peptide RADA16-I is a 4-repetition arginine-alanine-aspartic acid-alanine sequence, namely (arginine-alanine-aspartic acid-alanine) 4 , when its aqueous solution is adjusted to pH = 7, it will form a hydrogel composed of nanofiber network, which is very similar to the structure of natural extracellular matrix. It has been widely used in the field of biomedical engineering as tissue engineering scaffold, drug carrier and hemostatic material , is a typical representative of self-assembled short peptide hydrogel materials. However, a significant disadvantage is that the aqueous solution of the material is obviously acidic (pH=3~4), and cannot be directly mixed with the cell suspension and active molecules to form a gel in situ, that is, it is difficult to realize cell embedding in RADA 16-I water. Three-dimensional growth in the gel.
目前关于细胞培养的报道仍是采用先制备水凝胶然后在其表面种植细胞的二维培养模式,不能实现真正的三维细胞培养。而将该材料直接注射体内修复损伤和用于止血时较低的pH会对宿主组织造成损害。自1993年首次报道该材料以来,人们对RADA16-I进行了大量的研究,但是对于其酸性的缺点仍不能有效解决。The current reports on cell culture still use the two-dimensional culture mode of preparing hydrogel and then planting cells on its surface, which cannot realize true three-dimensional cell culture. However, when the material is directly injected into the body to repair damage and is used for hemostasis, the lower pH will cause damage to the host tissue. Since the material was first reported in 1993, people have done a lot of research on RADA16-I, but the shortcoming of its acidity still cannot be effectively solved.
发明内容Contents of the invention
本发明根据目前自组装水凝胶材料中的不足,提供了一种中性pH下自组装成水凝胶的多肽材料。According to the deficiency in current self-assembled hydrogel materials, the present invention provides a polypeptide material self-assembled into hydrogel at neutral pH.
本发明的另一目的在于提供上述多肽材料的制备方法和应用。Another object of the present invention is to provide the preparation method and application of the above polypeptide material.
本发明的技术目的通过以下技术方案实现:Technical purpose of the present invention is achieved through the following technical solutions:
本发明提供了一种中性pH下自组装成水凝胶的多肽材料,包括在RADA16-I序列上分别连接多个酸性氨基酸和多个碱性氨基酸,以此形成两种带相反电荷的短肽,混合后自组装形成所述水凝胶的多肽材料。The present invention provides a polypeptide material that self-assembles into a hydrogel at neutral pH, including linking a plurality of acidic amino acids and a plurality of basic amino acids on the RADA16-I sequence to form two oppositely charged short The peptides, after mixing, self-assemble to form the polypeptide material of the hydrogel.
本发明是以低分子量自组装短肽为基础的水凝胶,为细胞三维生长提供空间,用于构建组织工程支架。本材料可在常温中性pH条件下形成纳米纤维水凝胶,模仿了天然细胞外基质结构,具有良好的理化性能和生物相容性,支持细胞三维生长,满足组织工程支架的要求,而且可负载活性分子药物,例如生长因子、短肽药物。可广泛应用于软骨、血管、神经、皮肤等人工器官的再生和损伤的修复。The invention is a hydrogel based on low-molecular-weight self-assembled short peptides, which provides space for three-dimensional growth of cells and is used for constructing tissue engineering scaffolds. This material can form nanofibrous hydrogel under the condition of normal temperature and neutral pH, which imitates the structure of natural extracellular matrix, has good physical and chemical properties and biocompatibility, supports three-dimensional growth of cells, meets the requirements of tissue engineering scaffolds, and can Load active molecular drugs, such as growth factors, short peptide drugs. It can be widely used in the regeneration and damage repair of artificial organs such as cartilage, blood vessels, nerves, and skin.
优选地,所述两种带相反电荷的短肽序列分别为Preferably, the two oppositely charged short peptide sequences are
序列1:(精氨酸-丙氨酸-天冬氨酸-丙氨酸)4-精氨酸-异亮氨酸-赖氨酸-缬氨酸-丙氨酸-缬氨酸;Sequence 1: (arginine-alanine-aspartic acid-alanine) 4 -arginine-isoleucine-lysine-valine-alanine-valine;
序列2:(精氨酸-丙氨酸-天冬氨酸-丙氨酸)4-谷氨酸-谷氨酸-酪氨酸-异亮氨酸-甘氨酸-丝氨酸-精氨酸。Sequence 2: (arginine-alanine-aspartic acid-alanine) 4 -glutamic acid-glutamic acid-tyrosine-isoleucine-glycine-serine-arginine.
优选地,所述两种带相反电荷的短肽序列分别为Preferably, the two oppositely charged short peptide sequences are
序列3:(精氨酸-丙氨酸-天冬氨酸-丙氨酸)4-(赖氨酸)n;Sequence 3: (arginine-alanine-aspartic acid-alanine) 4- (lysine) n ;
序列4:(精氨酸-丙氨酸-天冬氨酸-丙氨酸)4-谷氨酸-谷氨酸-天冬氨酸-天冬氨酸-天冬氨酸;Sequence 4: (arginine-alanine-aspartic acid-alanine) 4 -glutamic acid-glutamic acid-aspartic acid-aspartic acid-aspartic acid;
其中,n为1~10内任意一个自然数。Wherein, n is any natural number within 1~10.
申请人发现,在(精氨酸-丙氨酸-天冬氨酸-丙氨酸)4上接枝赖氨酸,并且与序列4进行混合,赖氨酸的接枝数量可以为1~10中任意一个自然数,这样形成的两对短肽混合后均可以实现中性pH下自组装的能力。The applicant found that the number of lysine grafted on (arginine-alanine-aspartic acid-alanine) 4 and mixed with sequence 4 can be 1~10 Any natural number in , the two pairs of short peptides formed in this way can realize the ability of self-assembly at neutral pH after mixing.
优选地,将所述两种带相反电荷的短肽分别配置成5~15mg/mL的水溶液,按照1:1的体积比混合,调节pH至中性,即得所述多肽材料。Preferably, the two oppositely charged short peptides are formulated into 5-15 mg/mL aqueous solutions, mixed according to a volume ratio of 1:1, and the pH is adjusted to neutral to obtain the polypeptide material.
本发明采用的技术方案是:在短肽(精氨酸-丙氨酸-天冬氨酸-丙氨酸)4序列上通过化学共价键连接多个酸性氨基酸为主的序列,例如如天冬氨酸和谷氨酸,或者连接多个碱性氨基酸为主的序列,例如赖氨酸、精氨酸和组氨酸。最终得到在中性pH条件下分别带有净正电荷和净负电荷的两条短肽序列,溶于水后调整其pH至7,两者混合后形成三维纳米多孔水凝胶。该水凝胶保持中性pH值,三维结构稳定。The technical scheme adopted in the present invention is: on the short peptide (arginine-alanine-aspartic acid-alanine) 4 sequence, a plurality of acidic amino acid-based sequences are connected through chemical covalent bonds, such as aspartic acid and glutamic acid, or linked to sequences dominated by multiple basic amino acids, such as lysine, arginine, and histidine. Finally, two short peptide sequences with a net positive charge and a net negative charge were obtained under neutral pH conditions. After being dissolved in water, the pH was adjusted to 7, and the two were mixed to form a three-dimensional nanoporous hydrogel. The hydrogel maintains a neutral pH value and has a stable three-dimensional structure.
本发明两对短肽序列的合成是采用了现有的接枝方向获得,由于目前未有成型的理论支持何种改性(即接枝序列和接枝位置)能够获得真正在中性条件下合成的自组装多肽水凝胶,不同的序列排列方式不同,电荷分布也不同,同时结构内部自组装方式均会影响最终的接枝效果,因此,上述接枝物的具体接枝位点和接枝序列排布,对最终效果影响非常大。The synthesis of the two pairs of short peptide sequences in the present invention is obtained by using the existing grafting direction. Since there is currently no established theory to support which modification (ie, grafting sequence and grafting position) can be obtained under neutral conditions. The synthesized self-assembled polypeptide hydrogels have different sequence arrangements and charge distributions. At the same time, the internal self-assembly mode of the structure will affect the final grafting effect. Therefore, the specific grafting sites and grafting properties of the above-mentioned grafts The sequence arrangement of branches has a great influence on the final effect.
与现有多肽自组装水凝胶相比,本发明在生理条件下(pH为7-7.4)即可形成三维多孔水凝胶,由直径约20 nm的纳米纤维网络构成,凝胶网络结构稳定,可为细胞三维培养提供支撑作用。将含有功能性氨基酸序列引入,能够促进细胞生长、粘附,同时也可负载活性分子药物,如生长因子、短肽药物,获得控制释放。也可注射使用,操作简便,是非常理想的生物材料。Compared with the existing polypeptide self-assembled hydrogel, the present invention can form a three-dimensional porous hydrogel under physiological conditions (pH 7-7.4), which is composed of a nanofiber network with a diameter of about 20 nm, and the gel network structure is stable , can provide support for three-dimensional cell culture. The introduction of functional amino acid sequences can promote cell growth and adhesion, and can also be loaded with active molecular drugs, such as growth factors and short peptide drugs, to obtain controlled release. It can also be used for injection, and is easy to operate, and is an ideal biological material.
本发明所述的中性pH下自组装成水凝胶的多肽材料,并且使用过程都是中性的,不会对细胞核宿主组织产生危害,能够用于真正的三维培养细胞,方法为将细胞悬液分别与所述两种带相反电荷的短肽进行混合,然后将两者混合,得到包埋细胞的水凝胶/细胞复合体,并加入培养基进行培养。The polypeptide material self-assembled into hydrogel under neutral pH of the present invention is neutral during use and will not cause harm to the nucleus host tissue, and can be used for real three-dimensional culture cells. The suspension is mixed with the two oppositely charged short peptides respectively, and then the two are mixed to obtain a cell-embedded hydrogel/cell complex, which is added to a culture medium for culturing.
进一步地,所述的中性pH下自组装成水凝胶的多肽材料在运用于软骨、血管、神经或皮肤的再生和损伤修复中,具有极大的应用前景。Furthermore, the polypeptide material self-assembled into hydrogel at neutral pH has great application prospects in the regeneration and repair of cartilage, blood vessels, nerves or skin.
与现有技术相比,本发明具有以下有益效果:Compared with the prior art, the present invention has the following beneficial effects:
本发明提供了一种可在常温中性pH条件,即在人体生理条件自组装形成三维多孔纳米纤维水凝胶。利用本发明技术制备的材料具有更好的生物相容性,可实现原位负载细胞/活性分子以及体内原位注射,在细胞三维培养、组织工程生物支架材料和药物载体领域具有非常广阔的应用前景和临床应用价值。The invention provides a three-dimensional porous nanofiber hydrogel that can be self-assembled under normal temperature and neutral pH conditions, that is, under human physiological conditions. The material prepared by using the technology of the present invention has better biocompatibility, can realize in situ loading of cells/active molecules and in situ injection in vivo, and has very broad applications in the fields of three-dimensional cell culture, tissue engineering bioscaffold materials and drug carriers Prospect and clinical application value.
附图说明Description of drawings
图1为两种修饰改性后的短肽(P1、P2),混合后形成的水凝胶材料(P1+P2),向水凝胶扩散的细胞培养基未改变颜色,说明形成的水凝胶呈中性pH;原子力显微镜显示纳米纤维形貌,说明所形成的水凝胶是由纳米纤维构成的网络。Figure 1 shows the hydrogel material (P1+P2) formed after mixing two modified short peptides (P1, P2). The color of the cell culture medium diffused into the hydrogel did not change, indicating the formation of hydrogel The gel has a neutral pH; the atomic force microscope shows the morphology of nanofibers, indicating that the formed hydrogel is a network composed of nanofibers.
图2为三种材料的流变性能对比图,P1,P2为改性短肽,P1+P2为两者混合物。G’为储能模量,G”为损耗模量。P1和P2混合后G’大大升高,说明形成了稳定的水凝胶。Figure 2 is a comparison chart of the rheological properties of the three materials, P1 and P2 are modified short peptides, and P1+P2 is a mixture of the two. G' is the storage modulus, and G" is the loss modulus. After mixing P1 and P2, G' increases greatly, indicating that a stable hydrogel is formed.
图3为神经干细胞球在不同纳米纤维水凝胶中三维生长形貌。A为本发明专利制备的纳米纤维水凝胶;B为 RADA 16-I纳米纤维水凝胶;从图中可以看出神经干细胞球在本发明专利制备的纳米纤维水凝胶中可以三维生长,并长出较长的轴突,而在RADA 16-I水凝胶中则没有任何轴突长出。Figure 3 is the three-dimensional growth morphology of neural stem cell spheres in different nanofibrous hydrogels. A is the nanofiber hydrogel prepared by the patent of the present invention; B is the RADA 16-I nanofiber hydrogel; it can be seen from the figure that neural stem cell balls can grow three-dimensionally in the nanofiber hydrogel prepared by the patent of the present invention, And grow longer axons, while in RADA 16-I hydrogel, no axons grow.
图4为利用活死细胞检测试剂盒检测神经干细胞在不同三维支架中的存活,绿色代表活细胞,红色代表死细胞。A为本发明专利制备的纳米纤维水凝胶;B为 RADA 16-I纳米纤维水凝胶;从图中可以看出神经干细胞在本发明专利制备的纳米纤维水凝胶中大量存活,存活率达到100%,并可以三维生长,并长出较长的轴突,而在RADA 16-I水凝胶中则大量死亡,层圆球状,没有任何轴突长出。Figure 4 shows the detection of the survival of neural stem cells in different three-dimensional scaffolds using the living and dead cell detection kit, green represents living cells, and red represents dead cells. A is the nanofiber hydrogel prepared by the patent of the present invention; B is the RADA 16-I nanofiber hydrogel; it can be seen from the figure that neural stem cells survive in large quantities in the nanofiber hydrogel prepared by the patent of the present invention, and the survival rate It reaches 100%, and can grow three-dimensionally, and grow longer axons, while in RADA 16-I hydrogel, a large number of dead, layered spherical, without any axon growth.
具体实施方式detailed description
下面通过实施例对本发明进行具体描述,有必要在此指出的是本实施例只用于对本发明进行进一步说明,但不能理解为对本发明保护范围的限制,该领域的技术熟练人员可以根据上述本发明的内容作出一些非本质的改进和调整。The present invention is described in detail by the following examples, it is necessary to point out that this example is only used to further illustrate the present invention, but can not be interpreted as limiting the protection scope of the present invention, those skilled in the art can according to above-mentioned this invention The content of the invention makes some non-essential improvements and adjustments.
除非特别说明,本发明采用的试剂、方法和设备为本技术领域常规试剂、方法和设备。Unless otherwise specified, the reagents, methods and equipment used in the present invention are conventional reagents, methods and equipment in the technical field.
实施例1:水凝胶的多肽材料制备:Embodiment 1: Preparation of polypeptide material of hydrogel:
序列1 (P1):(精氨酸-丙氨酸-天冬氨酸-丙氨酸)4-精氨酸-异亮氨酸-赖氨酸-缬氨酸-丙氨酸-缬氨酸溶于超纯水后,配置成浓度为5~15ml/mL的溶液,用NaOH调节其pH值至7,可得到带正电荷的短肽水溶液。Sequence 1 (P1): (arginine-alanine-aspartic acid-alanine) 4 -arginine-isoleucine-lysine-valine-alanine-valine After being dissolved in ultrapure water, it is configured into a solution with a concentration of 5-15ml/mL, and its pH value is adjusted to 7 with NaOH to obtain a positively charged short peptide aqueous solution.
序列2 (P2):(精氨酸-丙氨酸-天冬氨酸-丙氨酸)4-谷氨酸-谷氨酸-酪氨酸-异亮氨酸-甘氨酸-丝氨酸-精氨酸溶于超纯水后,,配置成浓度为5~15ml/mL的溶液,用NaOH调节其pH值至7,可得到带负电荷的短肽水溶液。Sequence 2 (P2): (arginine-alanine-aspartic acid-alanine) 4 -glutamic acid-glutamic acid-tyrosine-isoleucine-glycine-serine-arginine After dissolving in ultrapure water, configure it into a solution with a concentration of 5-15ml/mL, adjust its pH value to 7 with NaOH, and obtain a negatively charged short peptide aqueous solution.
之后将两者溶液以1:1的体积比混合,静置后迅速形成凝胶,形状稳定后即可投入使用(见图1)。Then mix the two solutions at a volume ratio of 1:1, and quickly form a gel after standing still, and put it into use after the shape is stable (see Figure 1).
如图1所示,两者混合后形成水凝胶,流动性失去。As shown in Figure 1, after the two are mixed, a hydrogel is formed and fluidity is lost.
原子力显微镜显示纳米纤维形貌,由直径约20 nm的纳米纤维网络构成,说明所形成的水凝胶是由纳米纤维构成的网络,且凝胶网络结构稳定,可为细胞三维培养提供支撑作用。The atomic force microscope showed the morphology of nanofibers, which consisted of a network of nanofibers with a diameter of about 20 nm, indicating that the formed hydrogel was a network of nanofibers, and the structure of the gel network was stable, which could provide support for three-dimensional cell culture.
实施例2:水凝胶的多肽材料制备:Embodiment 2: preparation of the polypeptide material of hydrogel:
制备方法同实施例1,Preparation method is with embodiment 1,
序列3 (P1’):(精氨酸-丙氨酸-天冬氨酸-丙氨酸)4-(赖氨酸)1-10;n为1~10内任意一个自然数均可。Sequence 3 (P1'): (arginine-alanine-aspartic acid-alanine) 4 -(lysine) 1-10 ; n is any natural number within 1-10.
序列4(P2’):(精氨酸-丙氨酸-天冬氨酸-丙氨酸)4-谷氨酸-谷氨酸-天冬氨酸-天冬氨酸-天冬氨酸。Sequence 4 (P2'): (arginine-alanine-aspartic acid-alanine) 4 -glutamic acid-glutamic acid-aspartic acid-aspartic acid-aspartic acid.
实施例3:三维细胞培养Example 3: Three-dimensional cell culture
以超纯水为溶剂,配成浓度为5-15 mg/mL的P1及P2溶液,将细胞悬液分别与调整至中性pH的P1和P2混合,得到均匀的细胞/短肽混合物,用NaOH溶液调节其pH至中性,之后以1:1混合得到包埋有细胞的三维水凝胶,静置后迅速形成凝胶,加入细胞培养基进行培养。Using ultrapure water as solvent, prepare P1 and P2 solutions with a concentration of 5-15 mg/mL, mix the cell suspension with P1 and P2 adjusted to neutral pH respectively, to obtain a uniform cell/short peptide mixture, use The NaOH solution adjusted its pH to neutral, and then mixed it at a ratio of 1:1 to obtain a three-dimensional hydrogel embedded with cells. After standing still, the gel was formed rapidly, and the cell culture medium was added for cultivation.
实施例3中包埋细胞为神经干细胞球,如图3和4所示,可以看出神经干细胞球在本发明专利制备的纳米纤维水凝胶中可以三维生长,达到了100%的存活率,并长出较长的轴突,而在RADA 16-I水凝胶中则没有任何轴突长出。In Example 3, the embedded cells are neural stem cell spheres, as shown in Figures 3 and 4, it can be seen that the neural stem cell spheres can grow three-dimensionally in the nanofiber hydrogel prepared by the patent of the present invention, reaching a 100% survival rate. And grow longer axons, while in RADA 16-I hydrogel, no axons grow.
实施例4:三维细胞培养Example 4: Three-dimensional cell culture
以超纯水为溶剂,配成浓度为5-15 mg/mL的P1’及P2’溶液,将细胞悬液分别与调整至中性pH的P1和P2混合,得到均匀的细胞/短肽混合物,用NaOH溶液调节其pH至中性,之后以1:1混合得到包埋有细胞的三维水凝胶,静置后迅速形成凝胶,加入细胞培养基进行培养。Use ultrapure water as solvent to prepare P1' and P2' solutions with a concentration of 5-15 mg/mL, and mix the cell suspension with P1 and P2 adjusted to neutral pH to obtain a uniform cell/short peptide mixture , the pH was adjusted to neutral with NaOH solution, and then mixed at 1:1 to obtain a three-dimensional hydrogel embedded with cells, which quickly formed a gel after standing still, and was added to cell culture medium for cultivation.
实施例4包埋细胞为为神经干细胞球,其检测后的现象同实施例3的结果相同,与RADA 16-I水凝胶相比,本发明提供的纳米纤维水凝胶中可以三维生长,达到了100%的存活率,并长出较长的轴突,而在RADA 16-I水凝胶中则没有任何轴突长出。The embedded cells in Example 4 are neural stem cell spheres, and the detected phenomenon is the same as the result of Example 3. Compared with the RADA 16-I hydrogel, the nanofiber hydrogel provided by the present invention can grow three-dimensionally, A 100% survival rate was achieved with longer neurite outgrowth, whereas in RADA 16-I hydrogel there was no axon outgrowth.
实施例:5:体内原位注射成凝胶Example: 5: In vivo in situ injection into a gel
在体内缺损部位依次注射P1和P2,即可形成凝胶。凝胶成中性,不会对周围组织造成伤害。Inject P1 and P2 sequentially at the defect site in the body to form a gel. The gel is neutral and will not cause damage to surrounding tissues.
在体内缺损部位依次注射P1’和P2’,即可形成凝胶。凝胶成中性,不会对周围组织造成伤害。Inject P1' and P2' sequentially at the defect site in the body to form a gel. The gel is neutral and will not cause damage to surrounding tissues.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510521915.1A CN105169474B (en) | 2015-08-24 | 2015-08-24 | Polypeptide material capable of carrying out self-assembly to form hydrogel under neutral pH condition and applications thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510521915.1A CN105169474B (en) | 2015-08-24 | 2015-08-24 | Polypeptide material capable of carrying out self-assembly to form hydrogel under neutral pH condition and applications thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105169474A CN105169474A (en) | 2015-12-23 |
CN105169474B true CN105169474B (en) | 2017-04-26 |
Family
ID=54892214
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510521915.1A Active CN105169474B (en) | 2015-08-24 | 2015-08-24 | Polypeptide material capable of carrying out self-assembly to form hydrogel under neutral pH condition and applications thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105169474B (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107029300A (en) * | 2016-02-04 | 2017-08-11 | 郑敦武 | A kind of purposes of nanoassemble hydrogel in operation antiblocking material |
CN107029287A (en) * | 2016-02-04 | 2017-08-11 | 郑敦武 | A kind of purposes of nanoassemble hydrogel in artificial dura mater material |
CN107029301A (en) * | 2016-02-04 | 2017-08-11 | 郑敦武 | A kind of purposes of nanoassemble hydrogel in operation for cranial nerve adherence preventing material |
CN106397545B (en) * | 2016-09-30 | 2019-06-21 | 暨南大学 | A kind of hydrogel material and its preparation method and application |
CN107041967A (en) * | 2016-11-29 | 2017-08-15 | 暨南大学 | A kind of feature self-assembled nanometer polypeptide hydrogel material and its application in hemostatic material is prepared |
CN106492268B (en) * | 2016-12-07 | 2019-04-19 | 中国石油大学(华东) | A kind of preparation method of short peptide/silica/hyaluronic acid composite hydrogel |
CN106821964A (en) * | 2017-02-09 | 2017-06-13 | 江苏食品药品职业技术学院 | The short chain polypeptides hydrogel and its methods for making and using same of pH regulation and control |
CN108517006B (en) * | 2018-05-10 | 2021-05-28 | 暨南大学 | A kind of polypeptide material that improves the dispersibility of carbon nanotubes in water under normal temperature and pressure conditions and its application |
CN109136165A (en) * | 2018-10-16 | 2019-01-04 | 罗忠礼 | A kind of application that self-assembled short peptide is quickly repaired in skin histology wound |
CN110423268A (en) * | 2019-04-25 | 2019-11-08 | 张胜有 | The polypeptide, hydrogel and its application of hydrogel can be self-assembled into |
JP6873436B2 (en) * | 2019-05-17 | 2021-05-19 | 学校法人大阪医科薬科大学 | Pharmaceutical composition for the treatment of joint diseases and its manufacturing method |
CN110330568B (en) * | 2019-07-23 | 2021-07-23 | 西南交通大学 | Functionalized and active self-assembled polypeptides, hydrogels, preparation methods, applications and bioscaffolds |
CN110615829B (en) * | 2019-09-29 | 2022-07-19 | 深圳市三浦天然化妆品有限公司 | Self-assembled antibacterial peptide hydrogel |
CN113633823B (en) * | 2021-07-19 | 2022-12-06 | 陕西未来多肽生物科技有限公司 | Functional self-assembly nano polypeptide hydrogel, preparation method, application and preparation |
CN116003826B (en) * | 2021-10-22 | 2024-12-20 | 中山大学附属第三医院(中山大学肝脏病医院) | Injectable modified hyaluronic acid/functional short peptide composite hydrogel and preparation method and application thereof |
CN114377202B (en) * | 2021-12-16 | 2023-01-24 | 方向前 | Functionalized self-assembled miRNA/polypeptide composite hydrogel suitable for cartilage regeneration and preparation method thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008127256A1 (en) * | 2006-06-01 | 2008-10-23 | Massachusetts Institute Of Technology | Control of cells and cell multipotentiality in three dimensional matrices |
CN102115498B (en) * | 2009-12-31 | 2013-11-06 | 华中科技大学同济医学院附属协和医院 | Connexin core sequence-containing amphiphilic polypeptide and application thereof |
CN103656618B (en) * | 2013-10-25 | 2016-06-08 | 广东药学院 | The treatment polypeptide nano fiber gel preparation of skin wound, preparation method and application |
CN104356402B (en) * | 2014-10-10 | 2016-08-31 | 孙念峰 | Functional self-assembled nanometer polypeptide hydrogel |
-
2015
- 2015-08-24 CN CN201510521915.1A patent/CN105169474B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN105169474A (en) | 2015-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105169474B (en) | Polypeptide material capable of carrying out self-assembly to form hydrogel under neutral pH condition and applications thereof | |
Chen et al. | Self-assemble peptide biomaterials and their biomedical applications | |
Gelain et al. | Designer self‐assembling peptide scaffolds for 3‐D tissue cell cultures and regenerative medicine | |
Luo et al. | Designer D-form self-assembling peptide nanofiber scaffolds for 3-dimensional cell cultures | |
Wu et al. | Hybrid hydrogels self-assembled from graft copolymers containing complementary β-sheets as hydroxyapatite nucleation scaffolds | |
CN106397545A (en) | Hydrogel material as well as preparation method and application thereof | |
CN103495209B (en) | Autofluorescence bone repairing magnetic sustained-release microspheres | |
CN102558304B (en) | Self-assembling peptide, and application of self-assembling peptide in promoting tumor cell to form multicellular spheroid | |
WO2008121447A1 (en) | Self-assembling membranes and related methods thereof | |
CN102718991A (en) | High strength injectable hydrogel and preparation method thereof | |
WO2004106359A2 (en) | Self-assembled peptide-amphiphiles & self-assembled peptide nanofiber networks presenting multiple signals | |
CN114224824B (en) | A kind of supramolecular hydrogel that can be used for lipophilic drug delivery and its preparation method and application | |
CN117982675A (en) | Double-targeting metal ion network hydrogel and preparation method and application thereof | |
CN101301494A (en) | A kind of hydrogel material for central nervous repair and its preparation method | |
ES2455441B1 (en) | USEFUL HYDROGEL AS INJECTABLE SUPPORT FOR APPLICATION IN CELLULAR THERAPY AND AS A CONTROLLED DRUG DELIVERY SYSTEM | |
CN113214359B (en) | A kind of polypeptide compound, polypeptide self-assembled network material and preparation method and application thereof | |
CN112646202B (en) | Functionalized double-network hydrogel and preparation method and application thereof | |
CN106390206B (en) | A kind of polypeptide hydrogel, preparation method and application | |
CN110339403B (en) | Spherical nano-hydroxyapatite/natural polymer biomimetic scaffold and preparation method | |
CN104650192A (en) | Self-assembling short peptides capable of repairing uterus and protecting cardiac muscle and application thereof | |
Bakker et al. | Supramolecular biomaterials based on ureidopyrimidinone and benzene-1, 3, 5-tricarboxamide moieties | |
CN118240020A (en) | Liquid positive charge responsive self-assembled peptide and application thereof | |
Park et al. | Neuronal differentiation of PC12 cells cultured on growth factor-loaded nanoparticles coated on PLGA microspheres | |
WO2024131923A1 (en) | Self-assembling peptide | |
WO2024131924A1 (en) | Broad-spectrum responsive self-assembling peptide and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190122 Address after: 510700 Guangzhou Hi-tech Industrial Development Zone, Guangdong Province, Room 806, 8th floor, Building B3, No. 11 Kaiyuan Avenue, Science City, Guangzhou Patentee after: Guangzhou Xin Sheng medical materials Co., Ltd. Address before: 510632 Whampoa Avenue, Guangzhou, Guangzhou, Guangdong Province, No. 601 Patentee before: Jinan University |